Inhibitor development in patients receiving recombinant factor VIII (Recombinate rAHF/Bioclate®): a prospective pharmacovigilance study.

Autor: Ewenstein, B. M.1 bruce_ewenstein@baxter.com, Gomperts, E. D.1, Pearson, S.1, O'Banion, M. E.1
Zdroj: Haemophilia. Sep2004, Vol. 10 Issue 5, p491-498. 8p.
Databáze: Academic Search Ultimate